Neuropathic pain in cancer patients: A brief review
Recommended Citation
Loomba V, Kaveeshvar H, Upadhyay A, Sibai N. Neuropathic pain in cancer patients: A brief review. Indian journal of cancer 2015; 52(3):425-428.
Document Type
Article
Publication Date
7-1-2015
Publication Title
Indian journal of cancer
Abstract
Neuropathic pain (NP) is initiated or caused by a primary lesion or dysfunction in the nervous system. The NP in cancer patients is typically due to a combination of inflammatory, neuropathic, ischemic, infiltrative, and compression mechanisms that involve one or more anatomic sites. These patients will often have various types of co-existing pain syndromes and co-morbidities. Thus, any treatment plan needs to be individualized. After a thorough clinical assessment and evaluation, a combination therapy including anticonvulsants, antidepressants, N-methyl-D-aspartate antagonists, opiates, topical agents, and interventional procedures should be considered in these patients.
Medical Subject Headings
Humans; Neoplasms; Neuralgia
PubMed ID
26905158
Volume
52
Issue
3
First Page
425
Last Page
428
